Your browser doesn't support javascript.
loading
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
Roodakker, Kenney R; Elsir, Tamador; Edqvist, Per-Henrik D; Hägerstrand, Daniel; Carlson, Joseph; Lysiak, Malgorzata; Henriksson, Roger; Pontén, Fredrik; Rosell, Johan; Söderkvist, Peter; Stupp, Roger; Tchougounova, Elena; Nistér, Monica; Malmström, Annika; Smits, Anja.
Afiliação
  • Roodakker KR; Department of Neuroscience, Neurology, Uppsala University, University Hospital, Uppsala, Sweden.
  • Elsir T; Department of Neuroscience, Neurology, Uppsala University, University Hospital, Uppsala, Sweden.
  • Edqvist PD; Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska R8:05, Karolinska University Hospital, Stockholm, Sweden.
  • Hägerstrand D; Department of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden.
  • Carlson J; Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Lysiak M; Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska R8:05, Karolinska University Hospital, Stockholm, Sweden.
  • Henriksson R; Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska R8:05, Karolinska University Hospital, Stockholm, Sweden.
  • Pontén F; Department of Cell Biology, Linköping University, Linköping, Sweden.
  • Rosell J; Department of Radiation Sciences & Oncology, Umeå University Hospital, Umeå, Sweden.
  • Söderkvist P; Regional Cancer Center, Stockholm Gotland, Stockholm, Sweden.
  • Stupp R; Department of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden.
  • Tchougounova E; Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Nistér M; Regional Cancer Center South East Sweden and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
  • Malmström A; Department of Advanced Home Care and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
  • Smits A; Department of Oncology, University Hospital Zurich, Zurich, Switzerland.
Oncotarget ; 7(45): 72431-72442, 2016 Nov 08.
Article em En | MEDLINE | ID: mdl-27626492
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Glioblastoma / Proteínas de Homeodomínio / Proteínas Supressoras de Tumor / Isocitrato Desidrogenase Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Glioblastoma / Proteínas de Homeodomínio / Proteínas Supressoras de Tumor / Isocitrato Desidrogenase Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suécia